274 related articles for article (PubMed ID: 9118958)
1. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
[TBL] [Abstract][Full Text] [Related]
2. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
Lindenboim L; Borner C; Stein R
Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
[TBL] [Abstract][Full Text] [Related]
3. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
4. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors.
Ishibashi Y; Nishimaki K; Asoh S; Nanbu-Wakao R; Yamada T; Ohta S
Biochem Biophys Res Commun; 1998 Feb; 243(2):609-16. PubMed ID: 9480856
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
6. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
Mei Y; Du W; Yang Y; Wu M
Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
[TBL] [Abstract][Full Text] [Related]
7. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
8. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
9. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
Lu L; Chaudhury P; Osmond DG
J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
[TBL] [Abstract][Full Text] [Related]
12. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
Boyd JM; Gallo GJ; Elangovan B; Houghton AB; Malstrom S; Avery BJ; Ebb RG; Subramanian T; Chittenden T; Lutz RJ
Oncogene; 1995 Nov; 11(9):1921-8. PubMed ID: 7478623
[TBL] [Abstract][Full Text] [Related]
13. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
14. Conformation of the Bax C-terminus regulates subcellular location and cell death.
Nechushtan A; Smith CL; Hsu YT; Youle RJ
EMBO J; 1999 May; 18(9):2330-41. PubMed ID: 10228148
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells regulate bcl-2 and bax expression in pro-B cells.
Gibson LF; Piktel D; Narayanan R; Nuñez G; Landreth KS
Exp Hematol; 1996 Apr; 24(5):628-37. PubMed ID: 8605968
[TBL] [Abstract][Full Text] [Related]
16. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
[TBL] [Abstract][Full Text] [Related]
17. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
Chau BN; Cheng EH; Kerr DA; Hardwick JM
Mol Cell; 2000 Jul; 6(1):31-40. PubMed ID: 10949025
[TBL] [Abstract][Full Text] [Related]
18. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes.
Fang W; Rivard JJ; Mueller DL; Behrens TW
J Immunol; 1994 Nov; 153(10):4388-98. PubMed ID: 7963517
[TBL] [Abstract][Full Text] [Related]
19. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Yin XM; Oltvai ZN; Korsmeyer SJ
Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
[TBL] [Abstract][Full Text] [Related]
20. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
